173 related articles for article (PubMed ID: 31142678)
21. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.
Lewis HD; Leveridge M; Strack PR; Haldon CD; O'neil J; Kim H; Madin A; Hannam JC; Look AT; Kohl N; Draetta G; Harrison T; Kerby JA; Shearman MS; Beher D
Chem Biol; 2007 Feb; 14(2):209-19. PubMed ID: 17317574
[TBL] [Abstract][Full Text] [Related]
22. Investigation of deregulated genes of Notch signaling pathway in human T cell acute lymphoblastic leukemia cell lines and clinical samples.
Paryan M; Mohammadi-Yeganeh S; Samiee SM; Soleimani M; Arefian E; Azadmanesh K; Poopak B; Mostafavi E; Karimipoor M; Mahdian R
Mol Biol Rep; 2013 Oct; 40(10):5531-40. PubMed ID: 23982259
[TBL] [Abstract][Full Text] [Related]
23. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
[TBL] [Abstract][Full Text] [Related]
24. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
25. A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling.
Zhang S; Cai F; Wu Y; Bozorgmehr T; Wang Z; Zhang S; Huang D; Guo J; Shen L; Rankin C; Tang B; Song W
Mol Psychiatry; 2020 Mar; 25(3):603-613. PubMed ID: 29915376
[TBL] [Abstract][Full Text] [Related]
26. Notch3-mediated regulation of MKP-1 levels promotes survival of T acute lymphoblastic leukemia cells.
Masiero M; Minuzzo S; Pusceddu I; Moserle L; Persano L; Agnusdei V; Tosello V; Basso G; Amadori A; Indraccolo S
Leukemia; 2011 Apr; 25(4):588-98. PubMed ID: 21263446
[TBL] [Abstract][Full Text] [Related]
27. Recent advances on NOTCH signaling in T-ALL.
Tzoneva G; Ferrando AA
Curr Top Microbiol Immunol; 2012; 360():163-82. PubMed ID: 22673746
[TBL] [Abstract][Full Text] [Related]
28. The NOTCH signaling pathway: role in the pathogenesis of T-cell acute lymphoblastic leukemia and implication for therapy.
Tosello V; Ferrando AA
Ther Adv Hematol; 2013 Jun; 4(3):199-210. PubMed ID: 23730497
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy of a PSEN1-selective γ-secretase inhibitor with dexamethasone and an XPO1 inhibitor to target T-cell acute lymphoblastic leukemia.
Vandersmissen C; Prieto C; Gielen O; Jacobs K; Nittner D; Maertens J; Segers H; Cools J
Haematologica; 2023 Sep; 108(9):2507-2512. PubMed ID: 36700404
[No Abstract] [Full Text] [Related]
30. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1.
Fragoso R; Mao T; Wang S; Schaffert S; Gong X; Yue S; Luong R; Min H; Yashiro-Ohtani Y; Davis M; Pear W; Chen CZ
PLoS Genet; 2012; 8(8):e1002855. PubMed ID: 22916024
[TBL] [Abstract][Full Text] [Related]
31. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
32. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
33. Gamma-secretase inhibitors suppress the growth of leukemia and lymphoma cells.
Kogoshi H; Sato T; Koyama T; Nara N; Tohda S
Oncol Rep; 2007 Jul; 18(1):77-80. PubMed ID: 17549349
[TBL] [Abstract][Full Text] [Related]
34. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
35. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
36. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
[TBL] [Abstract][Full Text] [Related]
37. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
[TBL] [Abstract][Full Text] [Related]
38. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
39. Synergistic antileukemic therapies in
Sanchez-Martin M; Ambesi-Impiombato A; Qin Y; Herranz D; Bansal M; Girardi T; Paietta E; Tallman MS; Rowe JM; De Keersmaecker K; Califano A; Ferrando AA
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2006-2011. PubMed ID: 28174276
[TBL] [Abstract][Full Text] [Related]
40. Targeting oncogenic Notch signaling with SERCA inhibitors.
Pagliaro L; Marchesini M; Roti G
J Hematol Oncol; 2021 Jan; 14(1):8. PubMed ID: 33407740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
